James P. O’Callaghan

421 total citations
9 papers, 340 citations indexed

About

James P. O’Callaghan is a scholar working on Rheumatology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James P. O’Callaghan has authored 9 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James P. O’Callaghan's work include Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). James P. O’Callaghan is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). James P. O’Callaghan collaborates with scholars based in Australia, Ireland and United Kingdom. James P. O’Callaghan's co-authors include Peter Brooks, M J Forrest, W.K. Seow, Chun Wai Wong, Y.H. Thong, Sam Milliken, Ian P. Wicks, J Biggs, Kerry Taylor and Geoff McColl and has published in prestigious journals such as Clinical Chemistry, Lara D. Veeken and QJM.

In The Last Decade

James P. O’Callaghan

9 papers receiving 328 citations

Peers

Countries citing papers authored by James P. O’Callaghan

Since Specialization

Citations

This map shows the geographic impact of James P. O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. O’Callaghan more than expected).

Fields of papers citing papers by James P. O’Callaghan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. O’Callaghan. The network helps show where James P. O’Callaghan may publish in the future.

Co-authorship network of co-authors of James P. O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of James P. O’Callaghan. A scholar is included among the top collaborators of James P. O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. O’Callaghan. James P. O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A study into efficacy of omalizumab therapy in patients with severe persistent allergic asthma at a tertiary referral centre for asthma in Ireland 2013 ·QJM ·(unknown), Mazen Al‐Alawi, (unknown), James P. O’Callaghan, Stephen J. Lane	12
2	A pilot randomized trial comparing CD34‐selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis 2002 ·Arthritis & Rheumatism ·John J. Moore, Peter Brooks, Sam Milliken, J Biggs, Dávid Ma, M. Händel, Paul Cannell, R. Will, Simon Rule, David Joske, (unknown), Kerry Taylor, James P. O’Callaghan, Jeff Szer, Ian P. Wicks, Geoff McColl, (unknown), John A. Snowden	125
3	Norwegian crusted scabies treated with ivermectin. 1999 ·PubMed ·James P. O’Callaghan, (unknown), (unknown)	1
4	Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor 1992 ·Inflammation Research ·Chun Wai Wong, W.K. Seow, James P. O’Callaghan, Y.H. Thong	35
5	Sulfasalazine in early rheumatoid arthritis 1992 ·R. Ebringer, Michael Ahern, (unknown), Helen R. Griffiths, James P. O’Callaghan, G. Littlejohn, D. C. Lewis, R A Hazelton, D. R. Barraclough, A. Stockman, Richard Travers, (unknown), Gabor Major, (unknown), Peter Brooks, (unknown), R Laurent, P. McNaught, Christopher J. Needs	66
6	COMPARATIVE CONTROLLED TRIAL OF LOW-DOSE WEEKLY METHOTREXATE VERSUS AZATHIOPRINE IN RHUEMATIOD ARTHRITIS: 3-YEAR PROSPECTIVE STUDY 1990 ·Lara D. Veeken ·Mark Arnold, James P. O’Callaghan, Margaret McCredie, Elaine Beller, Diane Kelly, Peter Brooks	29
7	Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients 1988 ·Rheumatology International ·James P. O’Callaghan, M J Forrest, Peter Brooks	39
8	A longitudinal study of cholinesterase changes in pregnancy. 1988 ·Clinical Chemistry ·Robert Evans, James P. O’Callaghan, (unknown)	18
9	Plasma and synovial fluid gentisate in patients receiving salicylate therapy. 1985 ·PubMed ·(unknown), (unknown), Debra M. Imhoff, Felix Bochner, (unknown), James P. O’Callaghan	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact